USFDA 483 to IPCA, Silvassa, India (Inspected in April 2023 by Rajiv Srivastava & Kellia Hicks) cites deficient OOS investigations, probable root causes concluded without scientific justifications & manufacturing investigation, deviation investigations & CAPAs are not timely Read More..